COVID-19 trials registries data warehouse

http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47392

Dr M Christopher

dr.judith.chris@gmail.com

2020-09-18

Not recruiting

RCT

Randomized

Parallel

Open label

single-center

Treatment

1) Patients in the age group of 14 years and above <br/ >2) Both male and female patients <br/ >3) Confirmed cases of COVID 19 admitted for treatment in Shifa hospital, COVID positive confirmed by RT-PCR <br/ >4) Presence of IgM antibodies through rapid test kit <br/ >5) Willing to give consent for the study and take part actively <br/ >6) Patients willing to adhere to drugs protocol as per ICMR guidelines/ WHO guidelines <br/ >7) In test arm, patients who are accepting to AWB therapy in addition to standard drugs

1) Children lesser than 14 years of age <br/ >2) Presence of IgG antibodies through rapid test kit <br/ >3) Patients hypersensitive to blood products or blood transfusion <br/ >4) Any Co-morbid conditions <br/ >5) Patients who are critically ill are excluded from the study

2

Dr M Christopher

14

85

India

Moderate/severe disease at enrollment

4: Moderate/severe disease at enrollment

60

RT-PCR test turning negative is the end pointTimepoint: 14days

| Declared number of arm (2.0) differs from found arms (3.0)

Not reported

[{"arm_notes": "", "treatment_id": 146, "treatment_name": "Autologous blood", "treatment_type": "Advanced therapy medicinal products (atmp)", "pharmacological_treatment": "Biological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]